Bernard L Kasten Net Worth & Insider Trades

Bernard L Kasten - Director, Cleveland Biolabs Inc

As of October 29, 2012

What is Bernard L Kasten's Net Worth?

The current estimated net worth of Cleveland Biolabs Inc's Director, Bernard L Kasten, is estimated to be about $3.3M . Bernard L Kasten owns about 227,656 units of Cleveland Biolabs Inc common stock. In the last 5 years at Cleveland Biolabs Inc, Bernard L Kasten has sold an estimated value of $0 worth.

What is Bernard L Kasten's Past Insider Trading?

Bernard L Kasten's largest purchase order was 12,000 units , worth over $73.7K on November 22, 2010. In total, Bernard L Kasten has made about 11 transactions over 5 years of their time at Cleveland Biolabs Inc. Bernard L Kasten usually trades in June, with the busiest year in 2010 and 2012. The most recent transaction was a purchase order of 10,000 units , worth over $25.9K on August 15, 2011.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Bernard L Kasten

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

Cleveland Biolabs Inc Executive Compensation

Name
Year
Salary
Other Compensation
Total
Langdon L. Miller 2019 $73,725 - $77,625
Langdon L. Miller 2018 $119,550 - $119,550
Andrei Gudkov 2019 $66,138 - $66,138
Andrei Gudkov 2018 $110,941 - $110,941
Christopher Zosh 2019 $92,463 $11,031 $103,494
Christopher Zosh 2018 $73,031 $9,161 $82,192
Yakov Kogan 2019 $264,323 $50,607 $314,930
Yakov Kogan 2018 $276,000 $10,800 $286,800
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1318641/000143774920023024/cbli20201029_def14a.htm

What are Cleveland Biolabs Inc's Past Insider Trades?

Cleveland Biolabs Inc's most recent insider trade came on February 27, 2015 by Randy S Saluck who bought 1,891 units worth $6.47K . In the last 8 years, insiders at Cleveland Biolabs Inc have sold an estimated value of $1.16M and bought an estimated value of $275.69K worth of shares. Insider trading is most common in June, with the busiest year in 2010. The most active traders at the company are Yakov Kogan, Chief Executive Officer,  Andrei Gudkov, Chief Scientific Officer,  and Michael Fonstein, President .

Cytocom, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...